{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:51:54Z","timestamp":1789617114957,"version":"build-2803163510"},"reference-count":298,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632023TD05"],"award-info":[{"award-number":["2632023TD05"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX24_1024"],"award-info":[{"award-number":["KYCX24_1024"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010035","name":"Outstanding Youth Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["[2022] 3-16-190"],"award-info":[{"award-number":["[2022] 3-16-190"]}],"id":[{"id":"10.13039\/501100010035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010035","name":"Outstanding Youth Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240096"],"award-info":[{"award-number":["BK20240096"]}],"id":[{"id":"10.13039\/501100010035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018576","name":"Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373815"],"award-info":[{"award-number":["82373815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073795"],"award-info":[{"award-number":["82073795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104097"],"award-info":[{"award-number":["82104097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372113"],"award-info":[{"award-number":["82372113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.apsb.2025.10.016","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:38:55Z","timestamp":1761187135000},"page":"2250-2281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathology-directed drug delivery strategies: How to overcome blood\u2013brain barrier for the treatment of brain diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-7303","authenticated-orcid":false,"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.10.016_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2014.03.007","article-title":"Tryps and trips: cell trafficking across the 100-year-old blood\u2013brain barrier","volume":"37","author":"Bentivoglio","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood\u2013brain barrier: physiology and strategies for drug delivery","volume":"165-166","author":"Pandit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.apsb.2025.10.016_bib8","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.7150\/thno.72167","article-title":"Selective brain entry of lipid nanoparticles in haemorrhagic stroke is linked to biphasic blood\u2013brain barrier disruption","volume":"12","author":"Al-Ahmady","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood\u2013brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","article-title":"Phenotypic heterogeneity of the endothelium: II. Representative vascular beds","volume":"100","author":"Aird","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","article-title":"Derivation of blood\u2013brain barrier endothelial cells from human pluripotent stem cells","volume":"30","author":"Lippmann","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood\u2013brain barrier","volume":"35","author":"Langen","year":"2019","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.apsb.2025.10.016_bib14","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/CIRCRESAHA.120.317473","article-title":"Single-cell analysis of blood\u2013brain barrier response to pericyte loss","volume":"128","author":"M\u00e4e","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2025.10.016_bib16","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202715","article-title":"Functional immune cell\u2013astrocyte interactions","volume":"218","author":"Sanmarco","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2025.10.016_bib17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.10.016_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","article-title":"Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.10.016_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2025.10.016_bib20","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.3390\/ijms20164016","article-title":"Potential for tight junction protein-directed drug development using claudin binders and angubindin-1","volume":"20","author":"Hashimoto","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib21","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/pharmaceutics12121236","article-title":"Tight junction modulating bioprobes for drug delivery system to the brain: a review","volume":"12","author":"Tachibana","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.10.016_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood\u2013brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.apsb.2025.10.016_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","article-title":"Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation","volume":"9","author":"Luissint","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2025.10.016_bib24","first-page":"62","article-title":"Inhibition of the immunoproteasome LMP2 ameliorates ischemia\/hypoxia-induced blood\u2013brain barrier injury through the Wnt\/\u03b2-catenin signalling pathway","volume":"8","author":"Chen","year":"2021","journal-title":"Mil Med Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-8118-9-6","article-title":"Expression and localization of claudins-3 and -12 in transformed human brain endothelium","volume":"9","author":"Schrade","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2025.10.016_bib26","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1080\/15548627.2020.1851897","article-title":"Autophagy alleviates hypoxia-induced blood\u2013brain barrier injury via regulation of CLDN5 (claudin 5)","volume":"17","author":"Yang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2025.10.016_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood\u2013brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood\u2013brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.10.016_bib29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/physrev.00035.2003","article-title":"Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis","volume":"84","author":"Bazzoni","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1083\/jcb.201404140","article-title":"ZO-1 controls endothelial adherens junctions, cell\u2013cell tension, angiogenesis, and barrier formation","volume":"208","author":"Tornavaca","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2025.10.016_bib31","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.drudis.2020.05.007","article-title":"Tight junction modulators for drug delivery to the central nervous system","volume":"25","author":"Hashimoto","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.10.016_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.739699","article-title":"The structure and function of the glycocalyx and its connection with blood\u2013brain barrier","volume":"15","author":"Jin","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2020.1858856","article-title":"Cytochrome P450 expression and regulation in the brain","volume":"53","author":"Kuban","year":"2021","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2014.06.017","article-title":"Agile delivery of protein therapeutics to CNS","volume":"190","author":"Yi","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2025.10.016_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00018-021-04074-4","article-title":"The role of SLC transporters for brain health and disease","volume":"79","author":"Nguyen","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood\u2013brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2025.10.016_bib38","first-page":"1605","article-title":"L-Carnitine-conjugated nanoparticles to promote permeation across blood\u2013brain barrier and to target glioma cells for drug delivery via the novel organic cation\/carnitine transporter OCTN2","volume":"46","author":"Kou","year":"2018","journal-title":"Artif Cells, Nanomed Biotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib39","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.3390\/ijms20225674","article-title":"Excitatory amino acid transporters (EAATs): glutamate transport and beyond","volume":"20","author":"Magi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib40","doi-asserted-by":"crossref","first-page":"19197","DOI":"10.1074\/jbc.RA119.009371","article-title":"The solute carriers ZIP8 and ZIP14 regulate manganese accumulation in brain microvascular endothelial cells and control brain manganese levels","volume":"294","author":"Steimle","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.10.016_bib41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/0271678X241241908","article-title":"Metabolite transport across central nervous system barriers","volume":"44","author":"Carstens","year":"2024","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.apsb.2025.10.016_bib42","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.10.016_bib43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-022-00536-w","article-title":"The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease","volume":"17","author":"Bossaerts","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.apsb.2025.10.016_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-020-00209-0","article-title":"Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human","volume":"17","author":"Zhang","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2025.10.016_bib46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00018-014-1771-4","article-title":"Iron transport across the blood\u2013brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy","volume":"72","author":"McCarthy","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib47","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/pharmaceutics15061748","article-title":"Novel human\/non-human primate cross-reactive anti-transferrin receptor nanobodies for brain delivery of biologics","volume":"15","author":"Ru\u00e9","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.10.016_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib49","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4103\/1673-5374.335829","article-title":"The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease","volume":"17","author":"Zhang","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib50","article-title":"Hypoglycemic medicines in the treatment of Alzheimer's disease: pathophysiological links between AD and glucose metabolism","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.10.016_bib51","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101644R","article-title":"Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics","volume":"36","author":"Alata","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2025.10.016_bib52","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1038\/s41598-021-83198-w","article-title":"Defining the epitope of a blood\u2013brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor","volume":"11","author":"Sheff","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.10.016_bib53","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1471-4159.2001.00222.x","article-title":"Rapid transferrin efflux from brain to blood across the blood\u2013brain barrier","volume":"76","author":"Zhang","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2025.10.016_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307899120","article-title":"Pathogenic bacteria exploit transferrin receptor transcytosis to penetrate the blood\u2013brain barrier","volume":"120","author":"Cheng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.10.016_bib55","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.drudis.2021.02.008","article-title":"LDL receptors and their role in targeted therapy for glioma: a review","volume":"26","author":"Pawar","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.10.016_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jacbts.2021.09.011","article-title":"Interplay of low-density lipoprotein receptors, LRPs, and lipoproteins in pulmonary hypertension","volume":"7","author":"Calvier","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1292\/jvms.70.313","article-title":"Trans-endothelial and trans-epithelial transfer of lactoferrin into the brain through BBB and BCSFB in adult rats","volume":"70","author":"Kamemori","year":"2008","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib58","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.3390\/molecules27154922","article-title":"Receptor for advanced glycation end products (RAGE): a pivotal hub in immune diseases","volume":"27","author":"Yue","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2025.10.016_bib59","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.7150\/thno.87168","article-title":"Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction","volume":"13","author":"Chevaleyre","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib60","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/j.2040-4603.2021.tb00183.x","article-title":"Leptin and the blood\u2013brain barrier: curiosities and controversies","volume":"11","author":"Banks","year":"2021","journal-title":"Compr Physiol"},{"key":"10.1016\/j.apsb.2025.10.016_bib61","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/pharmaceutics14122719","article-title":"Current update on transcellular brain drug delivery","volume":"14","author":"Pawar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.10.016_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.apsb.2025.10.016_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.10.016_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147937","article-title":"Factors influencing the blood\u2013brain barrier permeability","volume":"1788","author":"Zhao","year":"2022","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood\u2013brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2012.01127.x","article-title":"Inflammatory cell trafficking across the blood\u2013brain barrier: chemokine regulation and in vitro models","volume":"248","author":"Takeshita","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater Today"},{"key":"10.1016\/j.apsb.2025.10.016_bib68","article-title":"P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease","volume":"8","author":"Ahmed","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2025.10.016_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/17425240902806383","article-title":"Differential receptor-mediated drug targeting to the diseased brain","volume":"6","author":"Rip","year":"2009","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2025.10.016_bib70","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2025.10.016_bib71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.10.016_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood\u2013brain barrier disruption in Alzheimer's disease","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib73","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/awz011","article-title":"Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression","volume":"142","author":"Yamazaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2025.10.016_bib74","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0271678X17690761","article-title":"Differing associations between A\u03b2 accumulation, hypoperfusion, blood\u2013brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease","volume":"38","author":"Miners","year":"2018","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.apsb.2025.10.016_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood\u2013brain barrier transporters: an overview of function, dysfunction in Alzheimer's disease and strategies for treatment","volume":"1870","author":"Chaves","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2025.10.016_bib76","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib77","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cpt.2035","article-title":"Abundance of P-glycoprotein and other drug transporters at the human blood\u2013brain barrier in Alzheimer's disease: a quantitative targeted proteomic study","volume":"109","author":"Storelli","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13061","article-title":"Pathological changes within the cerebral vasculature in Alzheimer's disease: new perspectives","volume":"32","author":"Fisher","year":"2022","journal-title":"Brain Pathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib79","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood\u2013brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.10.016_bib80","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3390\/ijms24032909","article-title":"Endothelial dysfunction in neurodegenerative diseases","volume":"24","author":"Fang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood\u2013brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2025.10.016_bib84","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.10.016_bib85","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.apsb.2025.10.016_bib86","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","article-title":"Vascular degeneration in Parkinson's disease","volume":"23","author":"Guan","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib87","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","article-title":"Striatal blood\u2013brain barrier permeability in Parkinson's disease","volume":"35","author":"Gray","year":"2015","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.apsb.2025.10.016_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","article-title":"\u03b1-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function","volume":"285","author":"Kuan","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107101","article-title":"The VEGFs\/VEGFRs system in Alzheimer's and Parkinson's diseases: pathophysiological roles and therapeutic implications","volume":"201","author":"Ceci","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib90","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and inflammation-an interesting interplay in Parkinson's disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105760","article-title":"The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson's disease","volume":"177","author":"Negi","year":"2024","journal-title":"Neurochem Int"},{"key":"10.1016\/j.apsb.2025.10.016_bib92","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s12264-022-00899-6","article-title":"Calcium homeostasis in Parkinson's disease: from pathology to treatment","volume":"38","author":"Zhang","year":"2022","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.apsb.2025.10.016_bib93","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2741\/4206","article-title":"Disruption of the blood\u2013brain barrier in Parkinson's disease: curse or route to a cure?","volume":"19","author":"Lee","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.apsb.2025.10.016_bib94","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/glia.24109","article-title":"Astrocytic VEGFA: an essential mediator in blood\u2013brain-barrier disruption in Parkinson's disease","volume":"70","author":"Lan","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.apsb.2025.10.016_bib95","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.3390\/ijms21228538","article-title":"Brain endothelial p-glycoprotein level is reduced in Parkinson's disease via a vitamin D receptor-dependent pathway","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib96","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.10.016_bib97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib98","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.3390\/ijms23095162","article-title":"Proteomics in multiple sclerosis: the perspective of the clinician","volume":"23","author":"Sandi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib99","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.10.016_bib100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","article-title":"Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?","volume":"123","author":"Antel","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib101","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the significance of blood\u2013brain barrier disruption in multiple sclerosis pathology and treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib102","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.apsb.2025.10.016_bib103","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1007\/s00415-005-5002-7","article-title":"The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage","volume":"252","author":"Bruck","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","article-title":"Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers","volume":"33","author":"Engelhardt","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2025.10.016_bib105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib107","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2025.10.016_bib108","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/17425247.2021.1873273","article-title":"Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM)","volume":"18","author":"Perrelli","year":"2021","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2025.10.016_bib109","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2174\/1381612822666161025155058","article-title":"Brain drug delivery systems for the stroke intervention and recovery","volume":"23","author":"Luo","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2025.10.016_bib110","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"de Leeuw FE. Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.10.016_bib111","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.110.974675","article-title":"Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes","volume":"123","author":"Fonarow","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2025.10.016_bib112","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","article-title":"Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke","volume":"35","author":"Wang","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.apsb.2025.10.016_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.apsb.2025.10.016_bib114","doi-asserted-by":"crossref","first-page":"12470","DOI":"10.1021\/acsnano.9b01808","article-title":"Selective liposomal transport through blood brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities","volume":"13","author":"Al-Ahmady","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib115","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1111\/cns.14368","article-title":"Monocyte-related cytokines\/chemokines in cerebral ischemic stroke","volume":"29","author":"Bai","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib116","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10072-007-0814-0","article-title":"Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke","volume":"28","author":"Lucivero","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib117","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood\u2013brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2025.10.016_bib118","doi-asserted-by":"crossref","first-page":"C252","DOI":"10.1152\/ajpcell.00151.2018","article-title":"Roles of blood\u2013brain barrier integrins and extracellular matrix in stroke","volume":"316","author":"Edwards","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2025.10.016_bib119","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/320941","article-title":"Blood brain barrier: a challenge for effectual therapy of brain tumors","volume":"2015","author":"Bhowmik","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.apsb.2025.10.016_bib120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.10.016_bib121","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.apsb.2025.10.016_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.apsb.2025.10.016_bib123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.10.016_bib124","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-011-0564-y","article-title":"Tissue concentration of systemically administered antineoplastic agents in human brain tumors","volume":"104","author":"Pitz","year":"2011","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.apsb.2025.10.016_bib125","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/ncomms5196","article-title":"Disruption of astrocyte\u2013vascular coupling and the blood\u2013brain barrier by invading glioma cells","volume":"5","author":"Watkins","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109369","article-title":"Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2025.10.016_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s004010000180","article-title":"Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme","volume":"100","author":"Liebner","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.apsb.2025.10.016_bib128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0808698106","article-title":"VEGF-mediated disruption of endothelial CLN-5 promotes blood\u2013brain barrier breakdown","volume":"106","author":"Argaw","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.10.016_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.922181","article-title":"Blood\u2013brain barrier alterations and edema formation in different brain mass lesions","volume":"16","author":"Solar","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114539","article-title":"Ultrasound-mediated blood\u2013brain barrier opening: an effective drug delivery system for theranostics of brain diseases","volume":"190","author":"Wang","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib132","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2019.00086","article-title":"Theranostic strategy of focused ultrasound induced blood\u2013brain barrier opening for CNS disease treatment","volume":"10","author":"Chen","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.10.016_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.06.023","article-title":"Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood\u2013brain barrier opening and brain drug delivery","volume":"192","author":"Chai","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib134","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.1073\/pnas.2002571117","article-title":"Noninvasive hippocampal blood\u2013brain barrier opening in Alzheimer's disease with focused ultrasound","volume":"117","author":"Rezai","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.10.016_bib135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41467-021-21022-9","article-title":"Blood\u2013brain barrier opening with focused ultrasound in Parkinson's disease dementia","volume":"12","author":"Gasca-Salas","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115323","article-title":"Recent advances of focused ultrasound induced blood\u2013brain barrier opening for clinical applications of neurodegenerative diseases","volume":"209","author":"Zhao","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib137","doi-asserted-by":"crossref","first-page":"11794","DOI":"10.7150\/thno.44152","article-title":"Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114822","article-title":"Magnetic iron oxide nanoparticles for brain imaging and drug delivery","volume":"197","author":"Qiao","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib139","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","article-title":"A decade of the protein corona","volume":"11","author":"Ke","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.apsb.2025.10.016_bib141","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2025.10.016_bib142","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12987-023-00489-2","article-title":"Breaking barriers: exploring mechanisms behind opening the blood\u2013brain barrier","volume":"20","author":"Stamp","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2025.10.016_bib143","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s12274-021-3865-2","article-title":"Nanomaterials for neurodegenerative diseases: molecular mechanisms guided design and applications","volume":"15","author":"Li","year":"2022","journal-title":"Nano Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib144","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","article-title":"Amyloid-\u03b2-targeting immunotherapies for Alzheimer's disease","volume":"375","author":"Jin","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib145","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood\u2013brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.apsb.2025.10.016_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311013","article-title":"Stealth liposomes encapsulating a potent ACAT1\/SOAT1 inhibitor F12511: pharmacokinetic, biodistribution, and toxicity studies in wild-type mice and efficacy studies in triple transgenic Alzheimer's disease mice","volume":"24","author":"De La Torre","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib147","article-title":"Microenvironment remodeling micelles for Alzheimer's disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.10.016_bib148","article-title":"Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer's disease by inflammatory microenvironment modulation","volume":"33","author":"Liu","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib149","first-page":"180","volume":"vol. 6","author":"Huang","year":"2023"},{"key":"10.1016\/j.apsb.2025.10.016_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood\u2013brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.10.016_bib151","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12951-023-01772-y","article-title":"Peripheral administration of nanomicelle-encapsulated anti-A\u03b2 oligomer fragment antibody reduces various toxic A\u03b2 species in the brain","volume":"21","author":"Amano","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib152","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","article-title":"Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer's disease therapy","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-023-01236-3","article-title":"Long-term effects of immunotherapy with a brain penetrating A\u03b2 antibody in a mouse model of Alzheimer's disease","volume":"15","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909999","article-title":"Endo\/lysosome-escapable delivery depot for improving BBB transcytosis and neuron targeted therapy of Alzheimer's disease","volume":"30","author":"Cai","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib155","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/s41467-019-12554-2","article-title":"Crossing the blood\u2013brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib156","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/ph13100314","article-title":"Brain-targeted delivery of pre-miR-29b using lactoferrin-stearic acid-modified-chitosan\/polyethyleneimine polyplexes","volume":"13","author":"Pereira","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2025.10.016_bib157","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jconrel.2023.12.003","article-title":"MicroRNA-195 liposomes for therapy of Alzheimer's disease","volume":"365","author":"Su","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib158","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","article-title":"Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer's disease","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib159","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41467-024-44814-1","article-title":"Endothelial leakiness elicited by amyloid protein aggregation","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2025.10.016_bib161","article-title":"Development of novel therapeutics targeting the blood\u2013brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.10.016_bib162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib163","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbapap.2011.02.011","article-title":"Binding studies of truncated variants of the A\u03b2 peptide to the V-domain of the RAGE receptor reveal A\u03b2 residues responsible for binding","volume":"1814","author":"Gospodarska","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2025.10.016_bib164","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"A\u03b21-42\u2013RAGE interaction disrupts tight junctions of the blood\u2013brain barrier via Ca2+\u2013calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib165","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s11095-017-2267-3","article-title":"Endothelial LRP1\u2014a potential target for the treatment of Alzheimer's disease","volume":"34","author":"Storck","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib166","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.10.016_bib167","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for efficiently conquering the blood\u2013brain barrier and targetedly suppressing multifocal and infiltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib168","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1007\/s12035-019-1594-2","article-title":"LRP1 has a predominant role in production over clearance of A\u03b2 in a mouse model of Alzheimer's disease","volume":"56","author":"Van Gool","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2025.10.016_bib169","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/febs.15148","article-title":"P-glycoprotein: a role in the export of amyloid-\u03b2 in Alzheimer's disease?","volume":"287","author":"Chai","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2025.10.016_bib170","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose transporters at the blood\u2013brain barrier: function, regulation and gateways for drug delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2025.10.016_bib171","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib172","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib173","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/acsnano.9b09991","article-title":"Dual-sensitive nanomicelles enhancing systemic delivery of therapeutically active antibodies specifically into the brain","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib174","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer's disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.apsb.2025.10.016_bib175","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood\u2013brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib176","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.molpharmaceut.8b00870","article-title":"Transferrin receptor-mediated uptake at the blood\u2013brain barrier is not impaired by Alzheimer's disease neuropathology","volume":"16","author":"Bourassa","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.10.016_bib177","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/pr.54.4.561","article-title":"Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway","volume":"54","author":"Qian","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib178","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib179","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1021\/acs.biomac.1c01109","article-title":"Effect of cationic charge density on transcytosis of polyethylenimine","volume":"22","author":"Chen","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2025.10.016_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202402445","article-title":"Revolutionizing neurocare: biomimetic nanodelivery via cell membranes","volume":"36","author":"Liao","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib181","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","article-title":"New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease","volume":"30","author":"Ou Yang","year":"2022","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2025.10.016_bib182","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","article-title":"Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies","volume":"358","author":"Liao","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib183","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.7150\/thno.81860","article-title":"Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against Alzheimer's disease","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib184","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood\u2013brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2018.11.034","article-title":"ScFv-conjugated superparamagnetic iron oxide nanoparticles for MRI-based diagnosis in transgenic mouse models of Parkinson's and Huntington's diseases","volume":"1707","author":"Liu","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib186","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acscentsci.2c00741","article-title":"Brain-targeted biomimetic nanodecoys with neuroprotective effects for precise therapy of Parkinson's disease","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib187","first-page":"578","article-title":"Nanomotor-based H2S donor with mitochondrial targeting function for treatment of Parkinson's disease","volume":"31","author":"Zhao","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib188","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2019.10.027","article-title":"GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice","volume":"315","author":"Zhao","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib189","article-title":"Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson's disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.10.016_bib190","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1021\/acsnano.2c12614","article-title":"Single-atom nanocatalytic therapy for suppression of neuroinflammation by inducing autophagy of abnormal mitochondria","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib191","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.10.016_bib192","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","article-title":"A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease","volume":"277","author":"Qu","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib193","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.10.016_bib194","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1189\/jlb.0710432","article-title":"Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte\u2013endothelial interactions","volume":"89","author":"Rossi","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2025.10.016_bib195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2019.03.008","article-title":"Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain","volume":"301","author":"Marcos-Contreras","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib196","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41593-023-01323-6","article-title":"The contribution of the peripheral immune system to neurodegeneration","volume":"26","author":"Berriat","year":"2023","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib197","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib198","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/biom10091327","article-title":"Extracellular vesicles as nanotherapeutics for Parkinson's disease","volume":"10","author":"Leggio","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2025.10.016_bib199","article-title":"Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood\u2013brain barrier","volume":"5","author":"Wang","year":"2025","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.apsb.2025.10.016_bib200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib201","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2025.10.016_bib202","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.10.016_bib203","article-title":"Efficient delivery of lomitapide using hybrid membrane-coated tetrahedral DNA nanostructures for glioblastoma therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib204","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40263-014-0160-8","article-title":"Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis","volume":"28","author":"Du Pasquier","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apsb.2025.10.016_bib205","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41590-022-01208-z","article-title":"Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation","volume":"23","author":"Yshii","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.10.016_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122084","article-title":"A cell-mimicking platelet-based drug delivery system as a potential carrier of dimethyl fumarate for multiple sclerosis","volume":"625","author":"Mehdi-Alamdarlou","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.10.016_bib207","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210262","article-title":"Trojan horse nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to Treg cells for the treatment of multiple sclerosis in mice","volume":"35","author":"Shi","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib208","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.10.016_bib209","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/pharmaceutics15041257","article-title":"Living cells and cell-derived vesicles: a Trojan horse technique for brain delivery","volume":"15","author":"Ou","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.10.016_bib210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155693","article-title":"MicroRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance","volume":"132","author":"Fujiwara","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.10.016_bib211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI80792","article-title":"Group A streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells","volume":"126","author":"Dileepan","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.10.016_bib212","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/10717544.2020.1831103","article-title":"Cell-mediated targeting drugs delivery systems","volume":"27","author":"Yu","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2025.10.016_bib213","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","article-title":"Outwitting the blood\u2013brain barrier for therapeutic purposes: osmotic opening and other means","volume":"42","author":"Kroll","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.apsb.2025.10.016_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood\u2013brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib215","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.7150\/thno.27466","article-title":"Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312897","article-title":"Blood\u2013brain barrier-penetrating and lesion-targeting nanoplatforms inspired by the pathophysiological features for synergistic ischemic stroke therapy","volume":"36","author":"Tang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib217","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41467-025-57278-8","article-title":"Serum-tolerant polymeric complex for stem-cell transfection and neural differentiation","volume":"16","author":"Jin","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib218","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12951-022-01461-2","article-title":"Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke","volume":"20","author":"Wang","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib219","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1021\/acs.nanolett.3c01567","article-title":"Shell-sheddable polymeric micelles alleviate oxidative stress and inflammation for enhanced ischemic stroke therapy","volume":"23","author":"Wang","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.10.016_bib220","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential","volume":"130","author":"Iadecola","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.10.016_bib221","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","article-title":"Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy","volume":"150","author":"Tian","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib222","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-019-0461-7","article-title":"Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice","volume":"17","author":"Zhang","year":"2019","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib223","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.nano.2016.03.005","article-title":"Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles","volume":"12","author":"Han","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2025.10.016_bib224","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood\u2013brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.10.016_bib225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib226","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib227","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1039\/D1BM01398J","article-title":"Passive targeting of high-grade gliomas via the EPR effect: a closed path for metallic nanoparticles?","volume":"9","author":"Caro","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib228","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2025.10.016_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib230","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.3390\/ijms22094556","article-title":"Transferrin-decorated niosomes with integrated InP\/ZnS quantum dots and magnetic iron oxide nanoparticles: dual targeting and imaging of glioma","volume":"22","author":"Ag Seleci","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib231","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib232","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","article-title":"Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma","volume":"365","author":"Wang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib233","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biomaterials.2011.10.035","article-title":"Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome","volume":"33","author":"Sun","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib234","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2023.03.003","article-title":"Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for glioma","volume":"259","author":"Ji","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib236","article-title":"Modulating nanozyme-based nanomachines via microenvironmental feedback for differential photothermal therapy of orthotopic gliomas","volume":"10","author":"Yin","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.10.016_bib237","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib239","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1039\/D0NH00077A","article-title":"A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma","volume":"5","author":"Kang","year":"2020","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.apsb.2025.10.016_bib240","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jconrel.2024.04.006","article-title":"A blood\u2013brain barrier- and blood\u2013brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy","volume":"369","author":"Tang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib241","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2015.12.006","article-title":"Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity","volume":"222","author":"Zhao","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122694","article-title":"Recent advances in biomimetic strategies for the immunotherapy of glioblastoma","volume":"311","author":"You","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib243","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pharmaceutics12010020","article-title":"ABC Transporters at the blood\u2013brain interfaces, their study models, and drug delivery implications in gliomas","volume":"12","author":"Gomez-Zepeda","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.10.016_bib244","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3390\/ijms18122544","article-title":"Obstacles to brain tumor therapy: key ABC transporters","volume":"18","author":"Wijaya","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib245","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13346-023-01401-z","article-title":"Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs)","volume":"14","author":"Hasan","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib246","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400630","article-title":"A targeted and responsive nanoprodrug delivery system for synergistic glioma chemotherapy","volume":"20","author":"Zhuo","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.10.016_bib247","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1715","article-title":"Nanomedicines for combating multidrug resistance of cancer","volume":"13","author":"Zhu","year":"2021","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib248","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.devcel.2019.10.028","article-title":"Role reversal: a ro-metastatic function of E-cadherin","volume":"51","author":"Shen","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.apsb.2025.10.016_bib249","first-page":"1146","article-title":"Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3","volume":"135","author":"Mammadova-Bach","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.10.016_bib250","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/cancers15102680","article-title":"Galectin-3 and epithelial MUC1 mucin-interactions supporting cancer development","volume":"15","author":"Radziejewska","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2025.10.016_bib251","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.10.016_bib252","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.actbio.2023.05.037","article-title":"Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy","volume":"166","author":"Sun","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.10.016_bib253","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib254","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acsnano.2c12217","article-title":"Engineering MMP-2 activated nanoparticles carrying B7-H3 bispecific antibodies for ferroptosis-enhanced glioblastoma immunotherapy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib255","doi-asserted-by":"crossref","first-page":"11285","DOI":"10.1039\/C9NR01320B","article-title":"Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy","volume":"11","author":"Fan","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2025.10.016_bib256","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.3390\/cancers13164226","article-title":"Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications","volume":"13","author":"Basheer","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2025.10.016_bib257","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/noy084","article-title":"Immunotherapy in CNS cancers: the role of immune cell trafficking","volume":"21","author":"Ratnam","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.apsb.2025.10.016_bib258","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib259","first-page":"624","article-title":"High-affinity mutant interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma","volume":"5","author":"Kim","year":"2020","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.10.016_bib261","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ymthe.2022.05.011","article-title":"Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors","volume":"30","author":"Yin","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2025.10.016_bib262","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.omto.2019.07.002","article-title":"B7-H3 as a novel CAR-T therapeutic target for glioblastoma","volume":"14","author":"Tang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.apsb.2025.10.016_bib263","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12967-023-04330-0","article-title":"Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2025.10.016_bib264","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/ijms21072263","article-title":"HSP70\/IL-2 treated NK cells effectively cross the blood brain barrier and target tumor cells in a rat model of induced glioblastoma multiforme (GBM)","volume":"21","author":"Sharifzad","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib265","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","article-title":"Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics","volume":"14","author":"Deng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib266","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202370371","article-title":"A trojan-horse-like biomimetic nano-NK to elicit an immunostimulatory tumor microenvironment for enhanced GBM chemo-immunotherapy","volume":"19","author":"Zhang","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.10.016_bib267","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","article-title":"Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy\/chemodynamic therapy of orthotopic glioma","volume":"15","author":"Xiao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib268","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib269","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1039\/D4BM00357H","article-title":"Macrophage membrane-camouflaged nanoclusters of ultrasmall iron oxide nanoparticles for precision glioma theranostics","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib270","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.10.016_bib271","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jconrel.2024.04.043","article-title":"Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines","volume":"370","author":"Shan","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib272","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1021\/acsnano.3c13088","article-title":"Brain delivery of biomimetic phosphorus dendrimer\/antibody nanocomplexes for enhanced glioma immunotherapy via immune modulation of T cells and natural killer cells","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib273","article-title":"Macrophage membrane-coated nanoparticles sensitize glioblastoma to radiation by suppressing proneural\u2013mesenchymal transformation in glioma stem cells","volume":"33","author":"Li","year":"2023","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib274","article-title":"Microfluidics-prepared ultra-small biomimetic nanovesicles for brain tumor targeting","volume":"13","author":"Wang","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib275","doi-asserted-by":"crossref","first-page":"31150","DOI":"10.1021\/acsami.3c03001","article-title":"Macrophage-cancer hybrid membrane-camouflaged nanoplatforms for HIF-1\u03b1 gene silencing-enhanced sonodynamic therapy of glioblastoma","volume":"15","author":"Li","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.10.016_bib276","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jconrel.2023.11.046","article-title":"Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy","volume":"365","author":"Zhou","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib277","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2023.12.033","article-title":"Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles","volume":"366","author":"Huang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.133848","article-title":"Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma","volume":"433","author":"Yin","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.apsb.2025.10.016_bib279","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.apsb.2022.09.016","article-title":"Salmonella-mediated blood\u2012brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy","volume":"13","author":"Mi","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.10.016_bib280","article-title":"Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo\/immuno glioblastoma therapy","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.10.016_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.10.016_bib282","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","article-title":"Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy","volume":"17","author":"Kuang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.10.016_bib283","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2021.06.015","article-title":"Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme","volume":"336","author":"Qiao","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib284","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12951-022-01360-6","article-title":"Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM","volume":"20","author":"Liu","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.10.016_bib285","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2024.02.015","article-title":"Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy","volume":"368","author":"Wang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib286","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002200","article-title":"Engineered microglia potentiate the action of drugs against glioma through extracellular vesicles and tunneling nanotubes","volume":"10","author":"Du","year":"2021","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.10.016_bib287","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.10.016_bib288","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2007.03.004","article-title":"Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection?","volume":"258","author":"Lazarowski","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apsb.2025.10.016_bib289","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.10.016_bib290","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300395","article-title":"Calcium phosphate-based nanoformulation selectively abolishes phenytoin resistance in epileptic neurons for ceasing seizures","volume":"19","author":"Guan","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.10.016_bib291","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.apsb.2025.10.016_bib292","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.7150\/thno.99260","article-title":"Macrophage membrane\u2012biomimetic nanoparticles target inflammatory microenvironment for epilepsy treatment","volume":"14","author":"Geng","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.10.016_bib293","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12974-023-02841-7","article-title":"Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood\u2012brain barrier disruption in anti-NMDA receptor encephalitis","volume":"20","author":"Chang","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.apsb.2025.10.016_bib294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2012.03.019","article-title":"Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets","volume":"65","author":"Denizot","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.apsb.2025.10.016_bib295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2023.09.043","article-title":"The innovative design of a delivery and real-time tracer system for anti-encephalitis drugs that can penetrate the blood\u2013brain barrier","volume":"363","author":"Wang","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.10.016_bib296","article-title":"Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy","volume":"2","author":"Zheng","year":"2022","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.apsb.2025.10.016_bib297","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14319","article-title":"Neurovascular dysfunction in psychiatric disorders: underlying mechanisms and therapeutic approaches","volume":"55","author":"Sanches","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.apsb.2025.10.016_bib298","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1007\/s12035-024-04205-5","article-title":"Unraveling the role of the blood\u2013brain barrier in the pathophysiology of depression: recent advances and future perspectives","volume":"61","author":"Varghese","year":"2024","journal-title":"Mol Neurobiol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525006938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525006938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:28:34Z","timestamp":1779823714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525006938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":298,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2211383525006938"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.10.016","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology-directed drug delivery strategies: How to overcome blood\u2013brain barrier for the treatment of brain diseases","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}